Annual Report

Overview

The report describes Nanologica's 2023 transition toward chromatography, with NLAB Saga approved and delivered to customers and used for the first time in diabetes-drug production. Drug development operations were discontinued at year-end as resources were redirected to chromatography. Sustainability content links the business to selected UN Sustainable Development Goals and describes policies covering conduct, HR, whistleblowing, and the environment, while noting that a broader sustainability framework is being developed.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services